Effects of deprescribing from inhaled corticosteroids in people with cystic fibrosis: protocol for a target trial emulation using the UK CF Registry
This study has received approval from the UK CF Registry Research Committee for both the research and access to data. Ethical approval has also been granted by the LSHTM Ethics Committee. The UK CF Registry has NHS Research Ethics Committee approval (REC reference: 24/EE/0012). The findings from this project will be submitted to peer-reviewed journals and presented at academic conferences.
Authors
- John Tazare (ORCID: https://orcid.org/0000-0002-7194-2615)
- Emily Granger (ORCID: https://orcid.org/0000-0003-0134-1467)
- Elliot McClenaghan (ORCID: https://orcid.org/0000-0002-0902-6122)
- Ruth H. Keogh (ORCID: https://orcid.org/0000-0001-6504-3253)
- Gwyneth Davies (ORCID: https://orcid.org/0000-0001-7937-2728)
- Julie Rouette (ORCID: https://orcid.org/0000-0003-3882-0998)
Institutions
- Great Ormond Street Hospital (GB)
- London School of Hygiene & Tropical Medicine (GB)
- GlaxoSmithKline (Canada) (CA)
- University College London (GB)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1136/bmjopen-2025-100894
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00